Overview

• The newly developed paint embeds chlorhexidine in epoxy resin, creating a germ-killing surface that remains effective without leaching into the environment.
• Laboratory tests showed the paint completely eliminates E. coli and Candida, reduces MRSA by 99.9%, and works against chlorhexidine-resistant strains.
• Durability trials confirmed the paint retains its antimicrobial properties after repeated exposures, leaching tests, and three months of storage.
• The technology uses commercially available materials, making it a cost-effective solution for healthcare and other high-risk environments.
• Further testing and optimization are ongoing to meet standards required for commercial approval and deployment.